Gender-Responsive Drug Use Treatment for Juvenile Justice Girls

描述（由申请人提供）：与非犯罪女性和男性犯罪同行相比，犯罪女孩患药物使用障碍、精神症状和负面健康结果（如艾滋病毒/艾滋病或其他性传播感染）的风险要大得多。研究表明，女孩可能有不同的发展道路，吸毒，最初的法律的参与和共同发生的负面健康结果，支持测试针对少年司法女孩的性别治疗的重要性。虽然最近越来越重视少年司法中针对性别的方案拟订，但缺乏有经验支持的针对性别的干预措施，以改善少年司法女孩的健康、心理健康和/或法律的结果。因此，本II期治疗试验的目的是在200名参与法庭审判的非监禁（CINI）女孩中测试预先存在的、广泛传播的性别敏感药物使用治疗（VOICES）的疗效。我们试图测试VOICES对CINI女孩的药物和酒精使用，艾滋病毒/性传播感染风险，精神症状和累犯的影响，并探索结果的调节因子和介导因子。将从罗得岛家庭法院招募12-18岁的CINI女孩（I期干预运行期间N= 6名青少年; II期RCT研究N=200名），并随机分配至VOICES（主动）干预组（n=100）或标准治疗（对照）组（n=100）。在第一阶段（第一年的前六个月），将招募6名青少年完成一次干预运行和研究评估，以便在RCT阶段之前测试RCT干预和评估程序。在第二阶段（第1年到第4年的下半年），将招募200名青少年，并在基线时进行随机分组，然后在治疗中期、治疗结束时以及干预后3、6、9和12个月的随访时进行重新评估。还将在每3个月评估时采集青少年吸毒和性传播感染（STI）的生物标本。功效试验结果可用于立即改变目前广泛的方案交付，从而直接影响以证据为基础的对青少年司法女孩的性别敏感的药物使用干预措施领域。

DESCRIPTION (provided by applicant): Compared to both non-offending females and male offending counterparts, offending girls are at significantly greater risk for the development of substance use disorders, psychiatric symptoms and negative health outcomes, such as HIV/AIDS or other sexually transmitted infections (STIs). Research suggests that girls may have different developmental pathways to drug use, initial legal involvement and co-occurring negative health outcomes that support the importance of testing gender-specific treatments for juvenile justice girls. Although there is recent increased emphasis on gender-specific programming in juvenile justice, empirically supported gender specific interventions to improve health, mental health and/or legal outcomes among juvenile justice girls are lacking. The objective of this Stage II treatment trial is therefore to test the efficacy of a pre-existing, widly disseminated gender-responsive drug use treatment (VOICES) among 200 court-involved, non- incarcerated (CINI) girls. We seek to test the effect of VOICES on CINI girls' drug and alcohol use, HIV/STI risk, psychiatric symptoms and recidivism as well as explore moderators and mediators of outcomes. CINI girls, ages 12-18 (N= 6 juveniles for Phase I Intervention Run-Through; N=200 for Phase II RCT study) will be recruited from the Rhode Island Family Court and randomized to either the VOICES (active) intervention (n=100) or a Standard of Care (control) condition (n=100). In Phase I (first six months of Year 1), 6 juveniles will be recruitedto complete the Intervention Run-Through and research assessment once to allow testing of RCT intervention and assessment procedures prior to the RCT phase. In Phase II (last half of Year 1 through Year 4), 200 juveniles will be recruited and randomized at baseline and then re-assessed at mid-treatment, end of treatment, and 3, 6, 9 and 12 month post-intervention follow-ups. Biological specimens for juvenile drug use and sexually transmitted infections (STIs) will also be collected at each 3-month assessment. Efficacy trial results can be used to make immediate changes to current widespread program delivery resulting in direct impact on the field of evidence-based gender-responsive substance use interventions for juvenile justice girls.